Empowering Women's Health: Meet the Artemis Foundation

Artemis Women's Health Foundation is a Swiss-based non-profit organization dedicated to revolutionizing women's health. Women's health is chronically underserved, with too few innovations reaching patients. Artemis is addressing this critical gap by fostering a thriving ecosystem for women's health innovation.

Through initiatives like Startup Vitamins webinars, Focused Meetups, and Stakeholder Round Tables, as well as the Artemis Database, the foundation connects scientists, entrepreneurs, investors, and industry leaders to accelerate the development of groundbreaking solutions. By breaking down silos and fostering collaboration, Artemis Women's Health Foundation aim to drive better diagnosis, treatment, and prevention for millions of women worldwide.

Gesynta Pharma is proud to be part of the Artemis community. Explore Artemis's vision for the future of endometriosis in their latest whitepaper: https://artemis.health/white-paper-endometriosis/


Learn more about Gesynta Pharma

Gesynta Pharma bases its R&D on groundbreaking research from the Karolinska Institutet.

The members of Gesynta Pharma's management team and board of directors have extensive experience from drug development and commercialization.

Endometriosis is a chronic, inflammatory, estrogen-dependent disease affecting millions of women worldwide.

Our lead drug candidate vipoglanstat is in clinical phase II for endometriosis, while GS-073 is ready to enter clinical phase I for chronic inflammatory pain.